Cargando…
Optimization of 2-Acylaminocycloalkylthiophene Derivatives for Activity against Staphylococcus aureus RnpA
Staphylococcus aureus is well-recognized to cause debilitating bacterial infections that are difficult to treat due to the emergence of antibiotic resistance. As such, there is a need to develop new antimicrobials for the therapeutic intervention of S. aureus disease. To that end, S. aureus RnpA is...
Autores principales: | Chojnacki, Michaelle, Cao, Xufeng, Flaherty, Daniel P., Dunman, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066339/ https://www.ncbi.nlm.nih.gov/pubmed/33807357 http://dx.doi.org/10.3390/antibiotics10040369 |
Ejemplares similares
-
Identification of Small Molecule Inhibitors of Staphylococcus aureus RnpA
por: Colquhoun, Jennifer M., et al.
Publicado: (2019) -
Staphylococcus aureus RnpA Inhibitors: Computational-Guided Design, Synthesis and Initial Biological Evaluation
por: Suigo, Lorenzo, et al.
Publicado: (2021) -
Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis
por: Olson, Patrick D., et al.
Publicado: (2011) -
Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance
por: Young, Mikaeel, et al.
Publicado: (2023) -
Repurposing the Antihistamine Terfenadine for Antimicrobial
Activity against Staphylococcus aureus
por: Perlmutter, Jessamyn I., et al.
Publicado: (2014)